New Test Distinguishes 'Broken Heart Syndrome' from Heart Attack
Scientists develop a scoring system for early diagnosis of stress-induced Takotsubo syndrome.
1What is Takotsubo Syndrome?
Takotsubo syndrome is a sudden heart condition triggered by intense emotional or physical stress. It primarily affects postmenopausal women, accounting for 2% of all suspected heart attack cases. Among women with acute coronary syndrome, this figure can reach 10%. The condition shows symptoms nearly identical to a heart attack in initial evaluations, making differentiation challenging.
2Diagnostic Challenges
Patients with Takotsubo syndrome experience chest pain, abnormal ECG results, and elevated cardiac enzyme levels - all mimicking heart attack symptoms. The key difference is the absence of blocked coronary arteries. As both conditions appear nearly identical initially, many patients undergo unnecessary invasive cardiac catheterization procedures before proper diagnosis.
3How BioTAK Score Works
Researchers from Zurich and Greifswald universities used AI to identify the most diagnostic biomarker combinations. The BioTAK score integrates biological sex with blood biomarkers linked to various cardiovascular processes. This clinical decision tool can accurately identify Takotsubo syndrome before catheterization, potentially reducing unnecessary invasive procedures.
4Test Accuracy
In an independent validation group of 1,800 patients, the BioTAK score diagnosed Takotsubo syndrome with 90% accuracy. Florian A. Wenzl from University of Zurich states, "A simple blood test combined with sex information can identify these patients with remarkable accuracy before catheterization." The biomarkers also provide insights into Takotsubo's distinct biological processes.
5Biological Mechanisms
Two novel biomarkers in the score highlight the crucial role of the brain-heart axis. One protein activates neuropeptides involved in stress responses and autonomic nervous system activity. The other relates to atherosclerotic plaque stability. Together, they reveal a biological pattern fundamentally different from classic heart attacks.
6Clinical Benefits
Thomas Lüscher from Imperial College London explains, "The BioTAK score translates complex disease mechanisms into a practical diagnostic tool." Christian Templin of Greifswald University adds that this method could reduce unnecessary invasive tests and improve early diagnosis for selected patients.
7Research Scope
The study utilized patient data from Switzerland, the SPUM-ACS Registry, and the International Takotsubo (InterTAK) Registry. Established in 2010, InterTAK is one of the world's largest Takotsubo research infrastructures. Published in the European Heart Journal, the research analyzed data from over 3,600 patients with either acute coronary syndrome or Takotsubo syndrome.
8Future Directions
Researchers continue investigating how incorporating the BioTAK score into routine clinical care could improve Takotsubo diagnosis and treatment. This innovation not only facilitates diagnosis but may also enhance understanding of the condition's underlying mechanisms, potentially leading to better therapeutic approaches.